Melanoma, vitiligo, and uveitis.
Albert
Daniel M
DM
D000951:Antigens, Neoplasm / Q000276:immunology; D001082:Aqueous Humor / Q000166:cytology / Q000378:metabolism; D015551:Autoimmunity; D003110:Colonic Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D016207:Cytokines / Q000378:metabolism; D004585:Electrooculography; D005434:Flow Cytometry; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000009:adverse effects*; D007376:Interleukin-2 / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D008545:Melanoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins / Q000276:immunology; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000628:therapy*; D041623:Tomography, Optical Coherence; D014607:Uveomeningoencephalitic Syndrome / Q000209:etiology* / Q000276:immunology; D058609:Visual Field Tests
D000951:Antigens, Neoplasm; D016207:Cytokines; D007376:Interleukin-2; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins